Manhattan Research Releases Latest Study Focused on How Nurses Use the Internet and Technology

Manhattan ResearchPharmaceutical and healthcare market research company Manhattan Research releases Taking the Pulse® Nurses v10.0, the latest iteration of its study focused on how nurses use digital resources, handheld devices, and other technologies in the professional setting. The market research and advisory service is based on in-depth interviews with over 1,000 U.S. nurses and physician assistants (PAs). Broad nurse market research can be segmented to provide insights for more than twenty specialist groups, including oncology, diabetes, and cardiology.

"With growing pressure to maximize prescription drug sales, marketers are increasingly looking to leverage highly influential touch points in the healthcare system beyond physicians, including nurses, payers, and pharmacists," said Monique Levy, Senior Director of Research at Manhattan Research. "Nurses represent a particularly strong opportunity for marketers - especially from a competitive standpoint - because their Internet and digital media adoption is highly advanced, but only a handful of brands have invested in the channel to date."

Key topics covered in the research include:

  • Technology and Internet Use for Professional Purposes: Technology and device ownership, websites visited during appointments, search engines, wikis, social networking websites, HCP online communities, newsletters, blogs, podcasts, attitudes toward Internet usage
  • Channel Mix: Sources used for professional information, including medical references, journals, and conferences
  • Email Use & Opportunity: Email usage and patient messaging/communication
  • Patient Interaction & Education: Source of patient education materials, websites recommended, influence on treatment decisions
  • Handheld Devices: Frequency, professional functions, clinical references, preferred points of access
  • Practice Technology: Electronic prescribing, EMR use and activities
  • Continuing Education: Current and future manner of completion (online, mobile, traditional), websites used
  • Practice Profile: Work setting, number of patients seen, number of prescriptions written
  • Digital Interaction with Pharma and Healthcare Companies: Top pharma properties, website features of interest, HCP service portals

About Taking the Pulse® Nurses
Taking the Pulse® Nurses was conducted in Q2 2010 among a nationally representative sample of 1,023 U.S. practicing nurses and physician assistants (PAs) via online survey methodology.

Healthcare and pharmaceutical marketers and other industry stakeholders use Taking the Pulse® Nurses to examine technology, media, channel, and promotional mix strategies as well as to benchmark their performance against industry competitors. In addition to analyzing overall market trends, clients can segment the study to derive statistically relevant insights across more than twenty specialist groups.

For additional product and subscription information, please visit http://www.manhattanresearch.com/ttpnurses.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among physicians and consumers, including Taking the Pulse®, Taking the Pulse® Nurses, Taking the Pulse® Europe, Taking the Pulse® Asia, Cybercitizen Health®, Cybercitizen Health® Europe, ePharma Consumer®, and ePharma Physician®. Broad consumer and physician research is complemented by targeted analysis for over 100 consumer therapeutic segments and physician specialist segments. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

Most Popular Now

Regorafenib to be tested in brain cancer patients …

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in the US ...

Sanofi and Google to develop new healthcare Innova…

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping i...

Bristol-Myers Squibb provides update on pending me…

Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: ...

Japan becomes the first country to approve Roche's…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of a...

Breztri Aerosphere (PT010) approved in Japan for p…

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy...

FDA approves Amgen and Allergan's KANJINTITM (tras…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTITM (trastuzumab-anns) for all approved ind...

Vitamin D may not help your heart

While previous research has suggested a link between low levels of vitamin D in the blood and an increased risk of cardiovascular disease, a new Michigan State University...

Human-on-a-chip model tests cancer drug efficacy a…

A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organ...

Pathogen engineered to self-destruct underlies can…

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-dest...

Artificial DNA can control release of active ingre…

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was o...

How gastric stem cells fight bacteria

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by re...

Researchers identify enzyme that suppresses immune…

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a ...